Upexi, Inc. (UPXI) — 10-Q Filings
All 10-Q filings from Upexi, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
UPEXI Swings to $66.7M Profit on Solana Bet, Digital Assets Soar
— Nov 12, 2025 Risk: high
UPEXI, INC. reported a significant financial turnaround for the three months ended September 30, 2025, achieving a net income of $66,748,122, a substantial impr -
UPEXI, INC. Files Q2 2025 10-Q
— Feb 14, 2025 Risk: low
UPEXI, INC. filed its 10-Q for the period ending December 31, 2024. The company, formerly known as GROVE, INC., is in the medicinal chemicals & botanical produc -
UPEXI, INC. Files Q1 2025 10-Q
— Dec 19, 2024 Risk: low
UPEXI, INC. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as GROVE, INC., is in the medicinal chemicals & botanical produ -
UPEXI, INC. Files 10-Q for Q3 2024
— Jul 9, 2024 Risk: low
UPEXI, INC. filed a 10-Q for the period ending March 31, 2024. The company, formerly known as GROVE, INC., is incorporated in Nevada and operates in the medicin -
UPEXI, INC. Files 10-Q for Period Ending December 31, 2023
— Feb 14, 2024 Risk: medium
UPEXI, INC. (UPXI) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. UPEXI, INC. reported financial results for the period ending December 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX